Noninvasive markers of liver disease in patients with HBeAg negative chronic hepatitis B and normal enzymes

Conclusion: None of the tested noninvasive indices could distinguish the significant liver fibrosis effectively. We suggest the use of platelets, γ-glutamyl transferase and γ-globulins, API, and fibroindex for monitoring disease severity and predicting prognosis. In suspicious cases, a more validated modality such as FibroScan can be performed.
Source: Egyptian Liver Journal - Category: Gastroenterology Tags: Original articles Source Type: research